According to the report, the global chemotherapy devices market was valued at approximately USD 11.1 billion in 2017 and is expected to generate around USD 18.8 billion by 2024, growing at a CAGR of around 7.9% between 2018 and 2024.
New York, NY, Dec. 31, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global chemotherapy devices market was valued at approximately USD 11.1 billion in 2017 and is expected to generate around USD 18.8 billion by 2024, growing at a CAGR of around 7.9% between 2018 and 2024.
Cancer is caused by uncontrolled and abnormal growth of cells. It can spread to other body parts and is one of the most fatal global diseases. Tobacco is responsible for around 33% of cancer cases worldwide. Poor diet, obesity, excessive alcohol consumption, and low physical activity are responsible for around 10% of cancer cases, exposure to environmental pollutants and ionizing radiation, infections, such as hepatitis B, hepatitis C, Epstein–Barr virus, human papillomavirus infection, and human immunodeficiency virus (HIV).
Browse through 62 Tables & 22 Figures spread over 110 Pages and in-depth TOC on “Global Chemotherapy Devices Market: By Types, Size, Share, Applications, Segments, Analysis and Forecast, 2017—2024”.
Request Free Sample Report of Global Chemotherapy Devices Market Report @ https://www.zionmarketresearch.com/sample/chemotherapy-devices-market
Cancer can be treated by using several techniques, such as surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, targeted therapy, stem cell therapy, and precision medicine. Chemotherapy involves blocking the progress of cancerous cells. Sometimes, chemotherapy is also used to ease cancerous symptoms by reducing the pain causing tumors. Chemotherapy can be directed orally as a pill, injected into body cavities, veins, muscles, or the spinal fluid. Currently, mostly chemotherapy is directed intravenously though oral chemotherapy medications are gaining wide acceptance across the world. Chemotherapy drugs are normally given in cycles. The cycle contains specific days’ medication followed by a break and recovery time. A chemotherapy cycle typically continues for one to four weeks and is increased. Each chemotherapy course is diverse but usually consists of four to six sessions. According to the Cancer Research UK, cancer was caused almost 9.6 million deaths worldwide in 2018. Most cases of cancer can be averted by following a healthy diet with lots of whole grains, vegetables, fruits, avoiding smoking and too much alcohol, and getting timely vaccination against infectious diseases.
The rising occurrences of multiple cancer types, such as sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are likely to act as the major growth driver for the chemotherapy devices market globally. Cancer is the second prominent cause of death globally. Furthermore, growing stress on research and development in oncology and the rising demand for precise and biological drug therapies are likely to propel this market in the future. However, unwillingness showed by patients to undergo chemotherapy might limit the chemotherapy devices market globally.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/chemotherapy-devices-market
The chemotherapy devices market is segmented into product and end-user. By product, this market is segmented into cannula, pump, catheter, and others. The end-user segment includes home care, clinics, and hospitals.
By region, this market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Europe is an established chemotherapy devices market, due to the increasing geriatric population, growing government expenditure on chemotherapy procedures through the National Health Service (NHS), favorable reimbursement policies, the increasing patient awareness, and advanced and well-developed healthcare infrastructure.
Browse the full “Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” Report at https://www.zionmarketresearch.com/report/chemotherapy-devices-market
North America is anticipated to display substantial growth in the near future. At the country level, the U.S. is the leading chemotherapy devices market in North America. The U.S. will progress at the highest CAGR in the projected timeframe. This growth can be attributed to the high occurrences of multiple types of cancers, the presence of advanced healthcare infrastructure, and the availability of skilled oncologists in the country.
The Asia Pacific chemotherapy devices market is expected to record the highest growth rate in the estimated time period. Japan, India, and China are projected to drive this regional chemotherapy devices market. This regional market’s growth is likely to be driven by the rise in the awareness regarding cancer diagnosis and treatment, huge consumption of tobacco and other cancer-causing agents, and the increase in the per capita healthcare spending of the population.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/chemotherapy-devices-market
The Latin American region is likely to record a swift rate of growth over the estimated time period, due to a huge patient pool, the rise in cancer prevalence, and rapid healthcare infrastructure growth. The Middle Eastern and African chemotherapy devices market is anticipated to witness a restricted rate of growth due to the shortage of skilled oncologists and absence of advanced infrastructure facilities in the region.
Some key players of the chemotherapy devices market include Baxter International Inc., B. Braun Melsungen AG, Advanced Chemotherapy Technologies, Becton, Dickinson and Company, Halyard Health, Terumo Corporation, Fresenius Kabi, Moog Inc., Smiths Group PLC, Zyno Medical, and Micrel Medical Devices S.A.
Request Customized Copy of Report @ https://www.zionmarketresearch.com/custom/3672
This report segments the global chemotherapy devices market as follows:
Global Chemotherapy Devices Market: By Product
Global Chemotherapy Devices Market: By End-User
- Home Care
Global Chemotherapy Devices Market: By Region
- North America
- The U.S.
- Asia Pacific
- Latin America
- The Middle East and Africa
- Medical Equipment Maintenance Market: https://www.zionmarketresearch.com/report/medical-equipment-maintenance-market
- Angiography Equipment Market: https://www.zionmarketresearch.com/report/angiography-equipment-market
- Hearing Aids Market: https://www.zionmarketresearch.com/report/hearing-aids-market
- Cochlear Implants Market: https://www.zionmarketresearch.com/report/cochlear-implants-market
- Microcarrier Market: https://www.zionmarketresearch.com/report/microcarrier-market
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrnewsanalysis.com
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
- Satsuma Pharmaceuticals Provides Business Update and ReportsSecond Quarter 2020 Financial Results - August 12, 2020
- New mystery-thriller follows Langsford as he attempts to solve a crime before he himself is accused - August 12, 2020
- Book presents the best etiquette, culture and most desirable mannerisms for waiting tables to earn excellent tips - August 12, 2020